However, findings in a systematic review and meta-analysis of prolonged NSAID use (ranging from one to seven years) indicated NSAIDs accelerate OA progression
There are currently almost 500 peptides recognized by the FDA as having therapeutic value to potentially treat various diseases, including [3]: Bone disorders Genetic disorders Cancer Infectious disease Cardiovascular problems Immune system Respiratory disorders Eye disorders Neurodegenerative problems Poor hormonal health Bone disorders Some of the most commonly used GHRH-promoting peptide drug products include tesamorelin, ipamorelin and sermorelin
Since glutathione deficiency and oxidative stress often contribute to nervous system conditions, glutathione supplementation may reduce symptoms and slow disease progression
Key Takeaway GHK-Cu side effects in women are generally mild and may include injection site redness, mild nausea, or temporary skin flushing
Use of NSAIDs in Treating Patients With Arthritis
And what worth would they even have